NGeneBio expands NGS-breast cancer diagnostic to Thailand (Korea Biomedical Review)
"NGeneBio said on Thursday that it launched its next-generation sequence (NGS)-based breast cancer diagnostic service in a newly installed inspection laboratory of a Thai consignment inspection agency, MP Group....NGeneBio plans to provide its NGS-based precision diagnosis services to medium and large hospitals, government-affiliated medical institutions, health centers, and the general public through MP Group's newly opened laboratory. The service launched by the MP Group laboratory uses NGeneBio’s BRCAaccuTest PLUS test to identify the BRCA gene which is related to breast cancer and ovarian cancer."